Research Bridge Partners
Jim Graham CFA is currently the Director of Investments at Research Bridge Partners and President of Tuebor Energy. Jim serves as a Board Member at Erisyon, IpiNovyx Bio, and Qana Therapeutics. Previously, Jim was the President of Strike Bio Inc and served as a Board Member at L7 Informatics and Laguna Pharmaceuticals. Throughout their career, Jim has shown a strong track record in managing businesses, acquisitions, clinical trials, and investments in the pharmaceutical and biotech industries. Jim holds a B.S. in Biological Sciences from Stanford University, a (HST) S.M. in Biomedical Sciences from Harvard Medical School, and an MBA from MIT Sloan School of Management. Jim's extensive experience and education make him a valuable asset in the field of life sciences.
This person is not in any teams
Research Bridge Partners
Research Bridge Partners makes formative investments in biomedical startup companies based on the breakthroughs of preeminent innovators at mid-continent research universities—creating high quality investment opportunities that are sourced from geographies with thinner commercialization resources.